Based on recent data, Leap Therapeutics, Inc. (LPTX) shows an Average True Range (ATR) of 0.21 and an Enterprise Value of 13.85M. Its average trading volume over the past 3 months is 1.82M, indicating liquidity. These fundamental metrics provide insight into LPTX's underlying financial health and market activity.
| ATR | 0.21 |
| Enterprise Value | 13.85M |
| Avg Vol (3 Months) | 1.82M |
| Avg Vol (10 Days) | - |
Leap Therapeutics, Inc. (LPTX) technical indicators as of May 5, 2026: the SMA 20 is 272.52%, SMA 50 at 325.67%, and SMA 200 at 409.57%. The RSI 14 value is 89.47, suggesting its current momentum. These technical analysis signals help assess LPTX's price trends and potential future movements.
| SMA 20 | 272.52% |
| SMA 50 | 325.67% |
| SMA 200 | 409.57% |
| RSI 14 | 89.47 |
Leap Therapeutics, Inc. (LPTX) stock performance overview as of May 5, 2026: The 52-week high is $2.54 (currently -43.21% below), and the 52-week low is $0.232 (currently 822.18% above). Over the past year, LPTX's performance is -87.51%, compared to the S&P 500's 16.14% change.
| 52-Week High | 2.54 |
| 52-Week High Chg | -43.21% |
| 52-Week Low | 0.2323 |
| 52-Week Low Chg | +822.18% |
| S&P 500 52-Week Chg | 16.14% |
According to market data, Leap Therapeutics, Inc. (LPTX) stock's recent performance metrics show that over the last month, LPTX is -33.19%, with a Year-to-Date (YTD) performance of -84.09%. Over the past year, the stock has seen a -87.51% change. These figures summarize LPTX's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 0.7319 | 0.8018 | 1.67 | 2.54 | 2.54 | 1.27 |
| Low | 0.5505 | 0.5 | 0.5 | 0.2697 | 0.2323 | 0.5 |
| Performance | +2.48% | -33.19% | +46.84% | +26.92% | -87.51% | -84.09% |
According to current financial data, LPTX stock's P/E (TTM) ratio is 10.56, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.22. Key valuation ratios for LPTX, including P/S (152.42), P/B (0.33), and P/FCF (-0.35), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | LPTX | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | 10.56 | -1.22 | -5.12 | 32.59 |
| P/S (TTM) | 152.42 | 3.69 | 464.32 | 5.98 |
| P/B (TTM) | 0.33 | 0.19 | 8293.8 | 4.61 |
| P/FCF (TTM) | -0.35 | -0.29 | -445.49 | 31.99 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep